UDkt Tho Lye Mun I-oncology

UDkt Tho Lye Mun uphakathi kwesazi esiphambili se-oncologist eKuala Lumpur Malaysia.

UDkt Tho Lye Mun waphothula izifundo ze-undergraduate kanye ne-postgraduate e-Australia nase-United Kingdom ngaphansi kwezinhlelo zemfundo yaphesheya. Ufaneleke kwi-Internal Medicine (MRCP) futhi uphethe iFellowship yeRoyal College of Radiologists UK eClinical Oncology (FRCR) kanye nokugunyazwa kochwepheshe base-UK. Wabe eseqhubeka nomsebenzi wobusosayensi wasemtholampilo wathola i-PhD kwi-oncology yamangqamuzana ngaphansi kohlelo oluhloniphekile lwe-CRUK / RCR lokuhlangana lapho anikezwa khona imiklomelo ehlukahlukene okubandakanya iJohn Paul Award kanye ne-Anne Hollman Medal. Usebenze njengoProfesa Ohlangene e-University Malaya ngaphambi kokudlulela emisebenzini yangasese.

Njengamanje uDkt Tho uyiPhini likaMongameli we-SEAROG (South East Asian Radiation Oncology Group) futhi ukhuthele ekuthuthukiseni amasu athuthukile emisebe isb. I-SRS, i-SBRT/SABR. Uphinde abe yiPhini likaMongameli we-LCNM (Lung Cancer Network yaseMalaysia). UDkt Tho ungumcwaningi okhuthele futhi wenze izivivinyo eziyimpumelelo ku-immunotherapy, umdlavuza wamaphaphu, umdlavuza wekhanda nentamo kanye nomdlavuza we-nasopharyngeal. Uyisikhulumi esimenywa njalo esifundeni nasemhlabeni jikelele.
Imiklomelo

1. UJohn Paul Award, Umfundi Ohamba Phambili We-PhD, UK
2. U-Anne Hollman Medal, iScotland Radiological Society, e-UK
3. Ukubambisana Kocwaningo Lomdlavuza, Ucwaningo Lomdlavuza UK (CRUK) / Royal College of Radiologists, UK
4. Iphepha Elihamba Phambili, Umhlangano Wesayensi Wonyaka, iRoyal College of Radiologists, e-UK
5. ICancer Cancer Fellowship, iBeatson Institute for Cancer Research, e-UK
6. UJohn Crawford Scholarship Wezokwelapha, e-Australia
7. I-ASEAN Scholarship, eSingapore

• Ummese weGamma neCyberknife SRS
• I-Intracranial Stereotactic Radiosurgery (i-SRS)
• I-Stereotactic Body Radiotherapy (SBRT)
• I-Stereotactic Ablative Body Radiotherapy (SABR)
• I-intension Modulated Radiotherapy (IMRT)
• I-Radiotherapy Eqondiswa Ngezithombe (IGRT)

Lung Cancer. 2019 Okthoba; 136: 65-73.

Ukuhlolwa kwamangqamuzana ngomdlavuza wamaphaphu weseli ongaphakeme osezingeni eliphakeme eMalaysia: Isitatimende seConsensus esivela eKolishi LamaPathologists, i-Academy of Medicine Malaysia, iMalsiansian Thoracic Society, neMalaysian Oncological Society. URajadurai P, Cheah PL, kanjani SH, Liam CK, Annuar MAA, Omar N, Othman N, Marzuki NM, Pang YK, Bustamam RSA, Thoko LM.

I-Lancet. 2019 May 4;393(10183):1819-1830.

I-Pembrolizumab kuqhathaniswa nokwelashwa ngamakhemikhali okwakungalashwa ngaphambilini, PD-L1-ukuveza, umdlavuza wamaphaphu ongeyona encane yamaseli (KEYNOTE-042): isilingo esingahleliwe, esivulekile, esilawulwayo, sesigaba 3. I-Mok et al KEYNOTE-042 Abaphenyi.

Imithi Yomdlavuza. 2015 Aug;4(8):1196-204.

Imikhuba yamanje ekuphathweni kobuhlungu bomdlavuza e-Asia: inhlolovo yeziguli nodokotela emazweni ayi-10. Iqembu le-ACHEON Working, Kim YC, Ahn JS, Calimag MM, Chao TC, Ho KY, Tho LM, Xia ZJ, Ward L, Inyanga H, Bhagat A.

I-Asian Pacific Journal yeCancer Prev. 2015;16(5):1901-6.

Izici zokubikezela ezigulini ezine-non-small cell lung carcinoma kanye ne-metastases yobuchopho: umbono waseMalaysia. I-Tang WH, Alip A, Saad M, Phua VC, Chandran H, Tan YH, Tan YY, Kua VF, Wahid MI, Thoko LM.

Umdlavuza we-BMC. 2014 uMashi 20; 14: 212

Ukuvala ukwahlukaniswa komdlavuza womhlaba wonke –ukusebenza kwezinsizakalo zokunakekelwa komdlavuza webele ezweni elisathuthuka eliphakathi. Lim GC, Aina EN, Cheah SK, Ismail F, Ho GF, Thoko LM, I-Yip Chet al HPMRS Iqembu Lokufunda Ngomdlavuza Webele.

Ukwelashwa Okuhlosiwe kanye ne-Immunotherapy Yomdlavuza WeLung

www.thestar.com.my/news/nation/2017/11/20/targeted-therapy-and-immunotherapy-for-lung-cancer

Ukukhulisa Uhlelo Lwethu Lokuzivikela Emzimbeni Ukulwa Nomdlavuza

https://www.star2.com/health/2018/09/05/boosting-immune-system-treat-tumours

Ukwenza i-Human Genome

https://www.nst.com.my/lifestyle/heal/2019/09/520171/profiling-human-genome

Ukubhekana Nomdlavuza Webele

https://www.nst.com.my/lifestyle/heal/2019/10/526132/facing-cancer